2YR-31346-62564
2 vaccinations
1 coded response
10 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 480 / MI
- Registered
- 2021-01-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-06
Dose 1 — Pfizer-BioNTech
-
2021-01-27
Registered in v-safe
-
2021-01-27
Dose 2 — Pfizer-BioNTech
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Hypoaesthesia, Lymphadenopathy, Swelling, Swelling face — Feeling: Fair · Muscle or body aches, Fatigue or tirednessFree text: Swelling in face, neck and lymph nodes; numbness in finger tipsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-30
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tiredness, DiarrheaAdult check-in
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-04-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-06 | Pfizer-BioNTech | |
| 2 | 2021-01-27 | Pfizer-BioNTech |
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Swelling in face, neck and lymph nodes; numbness in finger tips
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
| SRO | Swelling | ✓ | ✓ | ✓ |
| SRO | Swelling face | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release